PharmaCyte Biotech, Inc. 13D and 13G filings for Femasys Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-18 5:00 pm Sale | 2026-03-17 | 13G | FEMASYS INC FEMY | PharmaCyte Biotech Inc. PMCB | 4,932,825 7.870% | -7,779,039 (-61.20%) | Filing |
| 2023-11-22 4:00 pm Purchase | 2023-11-14 | 13D | FEMASYS INC FEMY | PharmaCyte Biotech Inc. PMCB | 12,711,864 37.000% | 12,711,864 (New Position) | Filing |